Development of docetaxel liposome surface modified with CD133 aptamers for lung cancer targeting-Reference-Cited by-同舟云学术

Development of docetaxel liposome surface modified with CD133 aptamers for lung cancer targeting

Published:2017-10-30 Issue: Volume: Page:1-8
ISSN:2169-1401
Container-title:Artificial Cells, Nanomedicine, and Biotechnology
language:en
Short-container-title:Artificial Cells, Nanomedicine, and Biotechnology

Author:

Ma Junzhe¹,Zhuang Huiru²,Zhuang Zhixiang¹,Lu Yufeng¹,Xia Rui¹,Gan Lei¹,Wu Yuantao¹

Affiliation:

1. Department of Oncology, The Second Affiliated Hospital of Soochow University, Institute of Radiotherapy & Oncology, Soochow University, Suzhou, China;

2. Department of Plastic Surgery, The Second Affiliated Hospital of Soochow University, Suzhou, China

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,Biomedical Engineering,General Medicine,Medicine (miscellaneous),Biotechnology

Link

https://www.tandfonline.com/doi/pdf/10.1080/21691401.2017.1394874

Reference28 articles.

1. Global Cancer Statistics, 2002

2. The biology of non-small-cell lung cancer: identifying new targets for rational therapy

3. Cancer statistics in China, 2015

4. New and emerging targeted treatments in advanced non-small-cell lung cancer

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipid-Based Nanocarriers for Targeted Gene Delivery in Lung Cancer Therapy: Exploring a Novel Therapeutic Paradigm;Current Gene Therapy;2025-04

2. Targeted Lipid-Based Drug Delivery Systems for Lung Cancer Therapy;Applied Sciences;2024-08-02

3. Aptamer-mediated therapeutic strategies provide a potential approach for cancer;International Immunopharmacology;2024-07

4. CD133 ligand‐enhanced etoposide‐liposome complex for targeted killing of lung cancer cells;Biotechnology Progress;2024-04

5. APTAMERS: NANOMATERIALS AS A POTENTIAL AGENT FOR ANTIVIRAL THERAPEUTIC DRUG DELIVERY DEVELOPMENT: A SYSTEMATIC LITERATURE REVIEW;International Journal of Applied Pharmaceutics;2024-01-07